February 24, 2026
According to market projections, the CRISPR sector is expected to grow from USD 3.27 billion in 2025 to USD 9.49 billion by 2035, reflecting a CAGR of 11.24%. The market is growing due to rising demand for gene-editing therapies in genetic disorders ...
April 21, 2026
According to market projections, the CRISPR technology sector is expected to grow from USD 5.72 billion in 2024 to USD 26.22 billion by 2034, reflecting a CAGR of 16.54%. In 2024, North America led the global CRISPR technology market, while Asia-Paci...
June 02, 2026
CRISPR Gene Editing Market (By Product: Products, Services; By Application: Biomedical; By End Use: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations; By Region: North America, Asia Paci...
May 04, 2026
Cell Line Development Market (By Product & Service: Reagents and media, Equipment, Automated Systems, Centrifuges, Bioreactors, Storage Equipment, Others, Accessories and consumables, Services; By Source: Mammalian cell line, Non-mammalian cell l...
May 06, 2026
Hearing Loss Gene Therapy Market (By Therapy Type: Gene Replacement Therapy, Gene Editing Therapy, RNA-Based Therapy; By Vector Type: Viral Vectors, Non-Viral Vectors; By Hearing Loss Type: Sensorineural Hearing Loss, Syndromic Hearing Loss, Acquired...
April 21, 2026
According to market projections, the nonspecific endonuclease market size to capture US$ 424.58 mn in 2025 and is to soar US$ 641.37 mn by 2030. The nonspecific endonuclease market is growing, driven by demand in gene therapy and genetic engineering,...
April 21, 2026
Market insights predict, the pneumonia testing industry is expected to grow from USD 1.97 billion in 2024 to USD 3.85 billion by 2034, driven by a CAGR of 6.97%. The rising prevalence of pneumonia and the growing demand for early diagnosis drive the ...
+1 9197 992 333
+91 93077 85324
